Characterisation of a planar dosimetry method estimating the absorbed dose to the bone marrow during 177Lu-DOTATATE treatment

被引：0
|
作者：
Hagmarker, L. [1 ]
Svensson, J. [2 ]
Magnander, T. [1 ]
Hemmingsson, J. [1 ]
Gjertsson, P. [3 ]
Bernhardt, P. [1 ]
机构：
[1] Univ Gothenburg, Sahlgrenska Acad, Dept Radiat Phys, Gothenburg, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Dept Oncol, Gothenburg, Sweden
[3] Sahlgrens Univ Hosp, Dept Clin Physiol, Gothenburg, Sweden
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2016年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP391
引用
收藏
页码：S120 / S120
页数：1
相关论文
共 50 条
  • [31] Kidneys functional volumes changes of patients undergoing 177Lu-DOTATATE treatment and the uncertainties measures in kidney dosimetry
    Khan, J.
    Ryden, T.
    Svensson, J.
    Van Essen, M.
    Bernhardt, P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S646 - S646
  • [32] Bone metastases affect bone marrow response during 177-Lu-DOTATATE treatments
    Svensson, J.
    Hagmarker, L.
    Ryden, T.
    Hermann, R.
    Wangberg, B.
    Sundlov, A.
    Sjogreen-Gleisner, K.
    Bernhardt, P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S400 - S401
  • [33] Prolonged response to 177Lu-DOTATATE therapy of a bone marrow infiltration in a refractory thymic neuro endocrine tumor
    Anne Ségolène Cottereau
    Léopoldine Bricaire
    Jennifer Arrondeau
    Amina Dechmi
    Françoise Montravers
    Romain Coriat
    Jerome Clerc
    Lionel Groussin
    Florence Tenenbaum
    [J]. Investigational New Drugs, 2020, 38 : 1196 - 1199
  • [34] Segmentation of Whole-Body Images into Two Compartments in Model for Bone Marrow Dosimetry Increases the Correlation with Hematological Response in 177Lu-DOTATATE Treatments
    Hagmarker, Linn
    Svensson, Johanna
    Ryden, Tobias
    Gjertsson, Peter
    Bernhardt, Peter
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2017, 32 (09) : 335 - 343
  • [35] Personalized therapy planning for 177Lu-DOTATATE using a kidney-driven dose optimization method
    Mirando, David
    Dewaraja, Yuni
    Kruzer, Alexandria
    Nelson, Aaron
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [36] Determination of Radiation Dose in 177Lu-DOTATATE Treatment with 99m-Tc-HYNICTATE Scintigraphy
    Yeyin, N.
    Toklu, T.
    Aygun, A.
    Karayel, E.
    Pehlivanoglu, H.
    Demirci, E.
    Demirci, M. Ocak
    Selcuk, N. Alan
    Demir, M.
    Kabasakal, L.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S362 - S362
  • [37] Fractional contribution of extrapolations in absorbed dose calculation to kidneys in 400 patients with neuroendocrine tumours receiving 177Lu-DOTATATE therapy
    Sandstrom, M.
    Garske-Roman, U.
    Granberg, D.
    Sundin, A.
    Lubberink, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S225 - S225
  • [38] Effects of imaging time points on uncertainty in absorbed dose to the kidneys in patients with neuroendocrine tumours receiving 177Lu-DOTATATE therapy
    Sandstrom, M.
    Ilan, E.
    Widstrom, C.
    Sundin, A.
    Lubberink, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S128 - S128
  • [39] Patient-specific pharmacokinetics and dosimetry over multiple therapy cycles during 177Lu-based radionuclide therapy: a study for 177Lu-DOTATATE and 177Lu-PSMA
    Gosewisch, A.
    Ermoschkin, L.
    Ilhan, H.
    Todica, A.
    Vamacka, L.
    Bartenstein, P.
    Boening, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S270 - S271
  • [40] Diagnostic 68Ga-DOTATOC imaging parameters and correlations with absorbed dose from 177Lu-DOTATATE treatment in GEP-NET-patients
    Bruvoll, R.
    Blakkisrud, J.
    Mikaelsen, L.
    Connelly, J.
    Stokke, C.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S336 - S337
12345